D, M., & CF, B. (2023). The MaxCombo Test Severely Violates the Type I Error Rate. JAMA oncology, 9(4), 571. https://doi.org/10.1001/jamaoncol.2022.7747
Chicago Style (17th ed.) CitationD, Magirr, and Burman CF. "The MaxCombo Test Severely Violates the Type I Error Rate." JAMA Oncology 9, no. 4 (2023): 571. https://doi.org/10.1001/jamaoncol.2022.7747.
MLA (9th ed.) CitationD, Magirr, and Burman CF. "The MaxCombo Test Severely Violates the Type I Error Rate." JAMA Oncology, vol. 9, no. 4, 2023, p. 571, https://doi.org/10.1001/jamaoncol.2022.7747.
Warning: These citations may not always be 100% accurate.